Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 366
5
Diseases
34
Unique genes
0.205
Avg. similarity score
C3 glomerulonephritis
Most-connected disease (3 links)
Disease
Searched: C3 glomerulonephritis
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
C3 glomerulonephritis
Hemolytic uremic syndrome
Mesangiocapillary glomerulonephritis
atypical hemolytic-uremic syndrome with B factor anomaly
hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| C3 glomerulonephritis | 3 | 3 | 8 |
| Hemolytic uremic syndrome | 3 | 3 | 33 |
| Mesangiocapillary glomerulonephritis | 3 | 3 | 8 |
| atypical hemolytic-uremic syndrome with B factor anomaly | 2 | 2 | 1 |
| hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| CFB | 4 / 5 | atypical hemolytic-uremic syndrome with B factor anomaly, C3 glomerulonephritis, Hemolytic uremic syndrome, Mesangiocapillary glomerulonephritis |
| C3 | 3 / 5 | C3 glomerulonephritis, Hemolytic uremic syndrome, Mesangiocapillary glomerulonephritis |
| CFH | 3 / 5 | C3 glomerulonephritis, Hemolytic uremic syndrome, Mesangiocapillary glomerulonephritis |
| CFHR1 | 3 / 5 | C3 glomerulonephritis, Hemolytic uremic syndrome, Mesangiocapillary glomerulonephritis |
| CFHR5 | 3 / 5 | C3 glomerulonephritis, Hemolytic uremic syndrome, Mesangiocapillary glomerulonephritis |
| CFI | 3 / 5 | C3 glomerulonephritis, Hemolytic uremic syndrome, Mesangiocapillary glomerulonephritis |
| C1GALT1C1 | 2 / 5 | Hemolytic uremic syndrome, hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature |
| CD46 | 2 / 5 | Hemolytic uremic syndrome, Mesangiocapillary glomerulonephritis |
| CFHR3 | 2 / 5 | C3 glomerulonephritis, Hemolytic uremic syndrome |
| DGKE | 2 / 5 | Hemolytic uremic syndrome, Mesangiocapillary glomerulonephritis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Complement and coagulation cascades | KEGG | 13 / 88 | 52.2× | 5.71e-20 | 3.89e-17 ✓ sig. |
| Regulation of Complement cascade | Reactome | 10 / 47 | 75.2× | 3.70e-17 | 1.61e-14 ✓ sig. |
| Interleukin-10 signaling | Reactome | 5 / 47 | 37.6× | 1.89e-7 | 1.14e-5 ✓ sig. |
| Malaria | KEGG | 5 / 50 | 35.3× | 2.59e-7 | 1.50e-5 ✓ sig. |
| Staphylococcus aureus infection | KEGG | 6 / 99 | 21.4× | 3.00e-7 | 1.71e-5 ✓ sig. |
| Hematopoietic cell lineage | KEGG | 6 / 100 | 21.2× | 3.19e-7 | 1.81e-5 ✓ sig. |
| AGE-RAGE signaling pathway in diabetic complications | KEGG | 6 / 101 | 21.0× | 3.38e-7 | 1.90e-5 ✓ sig. |
| Pertussis | KEGG | 5 / 78 | 22.6× | 2.44e-6 | 1.06e-4 ✓ sig. |
| African trypanosomiasis | KEGG | 4 / 37 | 38.2× | 3.31e-6 | 1.37e-4 ✓ sig. |
| Graft-versus-host disease | KEGG | 4 / 45 | 31.4× | 7.35e-6 | 2.66e-4 ✓ sig. |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 5 / 108 | 16.4× | 1.21e-5 | 4.00e-4 ✓ sig. |
| Legionellosis | KEGG | 4 / 56 | 25.2× | 1.77e-5 | 5.50e-4 ✓ sig. |
| Inflammatory bowel disease | KEGG | 4 / 66 | 21.4× | 3.41e-5 | 9.44e-4 ✓ sig. |
| Purinergic signaling in leishmaniasis infection | Reactome | 3 / 24 | 44.2× | 4.03e-5 | 1.09e-3 ✓ sig. |
| Fluid shear stress and atherosclerosis | KEGG | 5 / 141 | 12.5× | 4.39e-5 | 1.17e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| complement activation | GO:0006956 | 10 / 35 | 157× | 1.64e-20 | 2.80e-17 ✓ sig. |
| complement activation, alternative pathway | GO:0006957 | 4 / 16 | 137× | 1.64e-8 | 2.59e-6 ✓ sig. |
| vascular endothelial growth factor production | GO:0010573 | 3 / 6 | 275× | 1.10e-7 | 1.32e-5 ✓ sig. |
| positive regulation of vascular endothelial growth factor production | GO:0010575 | 4 / 32 | 68.7× | 3.17e-7 | 3.22e-5 ✓ sig. |
| acute-phase response | GO:0006953 | 4 / 37 | 59.4× | 5.78e-7 | 5.33e-5 ✓ sig. |
| complement activation, classical pathway | GO:0006958 | 4 / 37 | 59.4× | 5.78e-7 | 5.33e-5 ✓ sig. |
| cytolysis by host of symbiont cells | GO:0051838 | 3 / 11 | 150× | 8.99e-7 | 7.66e-5 ✓ sig. |
| positive regulation of nitric oxide biosynthetic process | GO:0045429 | 4 / 42 | 52.3× | 9.73e-7 | 8.17e-5 ✓ sig. |
| cellular response to lipopolysaccharide | GO:0071222 | 6 / 187 | 17.6× | 9.87e-7 | 8.26e-5 ✓ sig. |
| positive regulation of interleukin-6 production | GO:0032755 | 5 / 103 | 26.7× | 1.13e-6 | 9.25e-5 ✓ sig. |
| activation of membrane attack complex | GO:0001905 | 3 / 13 | 127× | 1.55e-6 | 1.20e-4 ✓ sig. |
| positive regulation of neuroinflammatory response | GO:0150078 | 3 / 16 | 103× | 3.03e-6 | 2.05e-4 ✓ sig. |
| positive regulation of blood microparticle formation | GO:2000334 | 2 / 2 | 550× | 3.21e-6 | 2.15e-4 ✓ sig. |
| defense response to Gram-positive bacterium | GO:0050830 | 5 / 135 | 20.4× | 4.30e-6 | 2.71e-4 ✓ sig. |
| positive regulation of macrophage derived foam cell differentiation | GO:0010744 | 3 / 21 | 78.5× | 7.16e-6 | 4.08e-4 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Hemolytic uremic syndrome | Mesangiocapillary glomerulonephritis | 0.235 | 8 | 1.77e-22 | 3.78e-21 ✓ sig. |
| C3 glomerulonephritis | Mesangiocapillary glomerulonephritis | 0.545 | 6 | 4.24e-20 | 8.15e-19 ✓ sig. |
| C3 glomerulonephritis | Hemolytic uremic syndrome | 0.200 | 7 | 8.39e-19 | 1.50e-17 ✓ sig. |
| atypical hemolytic-uremic syndrome with B factor anomaly | C3 glomerulonephritis | 0.111 | 1 | 5.20e-4 | 1.06e-3 ✓ sig. |
| atypical hemolytic-uremic syndrome with B factor anomaly | Mesangiocapillary glomerulonephritis | 0.111 | 1 | 5.20e-4 | 1.06e-3 ✓ sig. |
| Hemolytic uremic syndrome | hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature | 0.029 | 1 | 2.14e-3 | 3.04e-3 ✓ sig. |